Achenbach R - Search Results

1

A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies.

Agrelo R, Sutz MA, Setien F, Aldunate F, Esteller M, Da Costa V, Achenbach R. Agrelo R, et al. Among authors: achenbach r. Epigenetics. 2015;10(4):329-41. doi: 10.1080/15592294.2015.1027853. Epigenetics. 2015. PMID: 25830902 Free PMC article.

2

[Valve calcification in Werner's syndrome].

Monroy S, Pereiro G, Graziano A, Cola H, Palombo M, Achenbach R. Monroy S, et al. Among authors: achenbach r. Medicina (B Aires). 2010;70(4):372. Medicina (B Aires). 2010. PMID: 20679061 Spanish. No abstract available.

3

Paracoccidioidomycosis: unusual clinical presentation and utility of computerized tomography scanning for diagnosis.

Achenbach R, Negroni R, Khaski S, Lococo L, Beresñak A, Gai L. Achenbach R, et al. Int J Dermatol. 2002 Dec;41(12):881-2. doi: 10.1046/j.1365-4362.2002.01424.x. Int J Dermatol. 2002. PMID: 12492976 No abstract available.

4

Letter to the editor.

Achenbach RE. Achenbach RE. Dermatol Pract Concept. 2011 Jan 31;1(1):83-4. doi: 10.5826/dpc.dp0101a17. eCollection 2011. Dermatol Pract Concept. 2011. PMID: 24396726 Free PMC article. No abstract available.

5

Topical fish oil in psoriasis--a controlled and blind study.

Escobar SO, Achenbach R, Iannantuono R, Torem V. Escobar SO, et al. Among authors: achenbach r. Clin Exp Dermatol. 1992 May;17(3):159-62. doi: 10.1111/j.1365-2230.1992.tb00194.x. Clin Exp Dermatol. 1992. PMID: 1451289 Clinical Trial.

6

Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.

Bechara FG, Sand M, Achenbach RK, Sand D, Altmeyer P, Hoffmann K. Bechara FG, et al. Among authors: achenbach rk. Dermatol Surg. 2007 Aug;33(8):924-7. doi: 10.1111/j.1524-4725.2007.33193.x. Dermatol Surg. 2007. PMID: 17661934

7

Focal hyperhidrosis of the anal fold: a simple technique for diagnosis and evaluation of therapy.

Bechara FG, Sand M, Sand D, Achenbach RK, Altmeyer P, Hoffmann K. Bechara FG, et al. Among authors: achenbach rk. Br J Dermatol. 2006 Oct;155(4):858. doi: 10.1111/j.1365-2133.2006.07406.x. Br J Dermatol. 2006. PMID: 16965453 No abstract available.

8

Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.

Kereiakes DJ, Lincoff AM, Anderson KM, Achenbach R, Patel K, Barnathan E, Califf RM, Topol EJ; EPIC Investigators; EPILOG investigators; EPISTENT investigators. Kereiakes DJ, et al. Among authors: achenbach r. Am J Cardiol. 2002 Sep 15;90(6):628-30. doi: 10.1016/s0002-9149(02)02568-7. Am J Cardiol. 2002. PMID: 12231090 Clinical Trial. No abstract available.

9

[When sweating impairs life style. How your patients can become "dry". Interview by Petra Eiden].

Achenbach RK. Achenbach RK. MMW Fortschr Med. 2000 Jul 20;142(28-29):14. MMW Fortschr Med. 2000. PMID: 10959154 German. No abstract available.

10

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.

Kereiakes DJ, Berkowitz SD, Lincoff AM, Tcheng JE, Wolski K, Achenbach R, Melsheimer R, Anderson K, Califf RM, Topol EJ. Kereiakes DJ, et al. Among authors: achenbach r. Am Heart J. 2000 Jul;140(1):74-80. doi: 10.1067/mhj.2000.106615. Am Heart J. 2000. PMID: 10874266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page